Anika Therapeutics Inc (ANIK) is a Healthcare · Drug Manufacturers - Specialty & Generic company listed on NASDAQ. Price $20.64 (-1.85%), Market cap $0.20B, 52-week low–high $8.10 ~ $16.00.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain management products and services, such as Monovisc and Orthovisc, which are single- and multi-injection, HA viscosupplement products indicated for pain relief from OA conditions, as well as Cingal, a non-opioid, single-injection OA pain management product; regenerative solutions, including an HA-based scaffold with bone and tendon fixation components and arthroscopic delivery instruments; Hyalofast, a resorbable scaffold used for single stage cartilage regeneration; and Tactoset injectable bone substit
Financial statements, price targets, institutional (13F) holdings and related news for Anika Therapeutics Inc are updated in real time on BlackAll Trade.
Anika Therapeutics Inc trades at $20.64 (-1.85%). Real-time quotes and charts are available on BlackAll Trade.
Anika Therapeutics Inc has a market cap of about $0.20B.
Anika Therapeutics, Inc., a joint preservation company, focuses on early intervention orthopedics in the United States, Europe, and internationally. The company offers osteoarthritis (OA) pain managem